Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Electromed, Inc.ELMD · Entity 1958 | Director | December 01, 2025 | December 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Electromed, Inc.
Report date December 01, 2025 · Filed December 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,000 |
Reported balance
After 2025-12-01 transaction · row 1
1 source rowRow 1 · 2025-12-01 · Grant · Acquired 3,000 · Balance 15,000 F1: Restricted Stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated pursuant to their terms. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated pursuant to their terms.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CAS MEDICAL SYSTEMS INC
Report date April 18, 2019 · Filed April 22, 2019
Section 16 reporting ended · disclosed 2019-04-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-04-18 transaction · row 1
1 source rowRow 1 · 2019-04-18 · Disposition to issuer · Disposed 63,454 · Balance 0 F1: Each issued and outstanding share of common stock was, as a result of the consummation of the merger contemplated by the Agreement and Merger by and among CAS Medical Systems, Inc., Edwards Lifesciences Holding, Inc. and Crown Merger Sub, Inc., dated as of February 11, 2019 (the "Merger Agreement"), canceled in exchange for the right to receive a per share amount equal to $2.45 in cash without interest. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $2.54 · Expires 2021-06-09 | Direct | 0 |
Reported balance
After 2019-04-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-04-18 · Disposition to issuer · Disposed 20,000 · Balance 0 F2: This option, was, as a result of the consummation of the merger contemplated by the Merger Agreement, terminated on April 18, 2019. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.68 · Expires 2025-01-05 | Direct | 0 |
Reported balance
After 2019-04-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-04-18 · Disposition to issuer · Disposed 30,000 · Balance 0 F3: This option, which vested in two equal annual installments commencing on January 5, 2016, was, as a result of the consummation of the merger contemplated by the Merger Agreement, canceled in exchange for a cash payment equal to the product of the number of shares subject to such option multiplied by the excess of $2.45 over the exercise price per share of such option. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.64 · Expires 2025-12-17 | Direct | 0 |
Reported balance
After 2019-04-18 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-04-18 · Disposition to issuer · Disposed 15,000 · Balance 0 F4: This option, which vested in two equal annual installments commencing on December 17, 2016, was, as a result of the consummation of the merger contemplated by the Merger Agreement, canceled in exchange for a cash payment equal to the product of the number of shares subject to such option multiplied by the excess of $2.45 over the exercise price per share of such option. |
Filing footnotes · ownership attribution and instrument terms
F1: Each issued and outstanding share of common stock was, as a result of the consummation of the merger contemplated by the Agreement and Merger by and among CAS Medical Systems, Inc., Edwards Lifesciences Holding, Inc. and Crown Merger Sub, Inc., dated as of February 11, 2019 (the "Merger Agreement"), canceled in exchange for the right to receive a per share amount equal to $2.45 in cash without interest.
F2: This option, was, as a result of the consummation of the merger contemplated by the Merger Agreement, terminated on April 18, 2019.
F3: This option, which vested in two equal annual installments commencing on January 5, 2016, was, as a result of the consummation of the merger contemplated by the Merger Agreement, canceled in exchange for a cash payment equal to the product of the number of shares subject to such option multiplied by the excess of $2.45 over the exercise price per share of such option.
F4: This option, which vested in two equal annual installments commencing on December 17, 2016, was, as a result of the consummation of the merger contemplated by the Merger Agreement, canceled in exchange for a cash payment equal to the product of the number of shares subject to such option multiplied by the excess of $2.45 over the exercise price per share of such option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2025 Filed Dec 4, 2025 01:16 UTC | Electromed, Inc. ELMD · Entity 1958 | GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-036837 · rdgdoc.xml · nonDerivative · entry 1 Tune Kathleen A · CIK 0001522789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · shares: Restricted Stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 23:45 UTC | Electromed, Inc. ELMD · Entity 1958 | GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-036609 · rdgdoc.xml · nonDerivative · entry 1 Tune Kathleen A · CIK 0001522789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 F1 · shares: Restricted Stock scheduled to vest on June 1, 2025, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:32 UTC | Electromed, Inc. ELMD · Entity 1958 | GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033691 · rdgdoc.xml · nonDerivative · entry 1 Tune Kathleen A · CIK 0001522789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 F1 · shares: Restricted Stock scheduled to vest on June 1, 2024, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:34 UTC | Electromed, Inc. ELMD · Entity 1958 | GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-028441 · rdgdoc.xml · nonDerivative · entry 1 Tune Kathleen A · CIK 0001522789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 F1 · shares: Restricted Stock scheduled to vest on June 1, 2023, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:05 UTC | Electromed, Inc. ELMD · Entity 1958 | GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-027824 · rdgdoc.xml · nonDerivative · entry 1 Tune Kathleen A · CIK 0001522789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 F1 · shares: Restricted Stock scheduled to vest on June 1, 2022, unless earlier accelerated or terminated pursuant to their terms. Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 10:21 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | Disposition to issuerStock Option · Derivative | 15,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001449374-19-000009 · edgar.xml · derivative · entry 4 Tune Kathleen A · CIK 0001522789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2025-12-17 F4 · derivative.exercise_date: This option, which vested in two equal annual installments commencing on December 17, 2016, was, as a result of the consummation of the merger contemplated by the Merger Agreement, canceled in exchange for a cash payment equal to the product of the number of shares subject to such option multiplied by the excess of $2.45 over the exercise price per share of such option. Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 10:21 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | Disposition to issuerStock Option · Derivative | 30,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001449374-19-000009 · edgar.xml · derivative · entry 3 Tune Kathleen A · CIK 0001522789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2025-01-05 F3 · derivative.exercise_date: This option, which vested in two equal annual installments commencing on January 5, 2016, was, as a result of the consummation of the merger contemplated by the Merger Agreement, canceled in exchange for a cash payment equal to the product of the number of shares subject to such option multiplied by the excess of $2.45 over the exercise price per share of such option. Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 10:21 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | Disposition to issuerStock Option · Derivative | 20,000 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001449374-19-000009 · edgar.xml · derivative · entry 2 Tune Kathleen A · CIK 0001522789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2021-06-09 F2 · derivative.exercise_date: This option, was, as a result of the consummation of the merger contemplated by the Merger Agreement, terminated on April 18, 2019. Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 10:21 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | Disposition to issuerCommon Stock | 63,454 | $2.45 | $155,462.30 |
DisclosureSEC source: 0001449374-19-000009 · edgar.xml · nonDerivative · entry 1 Tune Kathleen A · CIK 0001522789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Each issued and outstanding share of common stock was, as a result of the consummation of the merger contemplated by the Agreement and Merger by and among CAS Medical Systems, Inc., Edwards Lifesciences Holding, Inc. and Crown Merger Sub, Inc., dated as of February 11, 2019 (the "Merger Agreement"), canceled in exchange for the right to receive a per share amount equal to $2.45 in cash without interest. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 12:34 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001449374-18-000039 · edgar.xml · nonDerivative · entry 1 Tune Kathleen A · CIK 0001522789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,454 F1 · price: Restricted stock grant vesting in two equal annual installments on 12/13/19 and 12/13/20. Read SEC document |
| December 21, 2017 Filed Dec 26, 2017 11:28 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001449374-17-000039 · edgar.xml · nonDerivative · entry 1 Tune Kathleen A · CIK 0001522789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,454 F1 · price: Restricted stock grant vesting in two equal installments on 12/21/18 and 12/21/19. Read SEC document |
| January 09, 2017 Filed Jan 11, 2017 09:42 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001449374-17-000002 · edgar.xml · nonDerivative · entry 1 Tune Kathleen A · CIK 0001522789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,454 F1 · price: Restricted stock grant vesting in two equal installments on 1/9/18 and 1/9/19. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.